BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4044 related articles for article (PubMed ID: 6732253)

  • 1. [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis].
    Ito Y; Jimbow K; Miura S; Maeda K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1263-8. PubMed ID: 6732253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of rIFN-gamma in the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration].
    Jimbow K; Yamana K; Ishida O; Kawamura M; Ito Y; Maeda K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):152-8. PubMed ID: 3099650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic response of interferon-beta in malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials of human fibroblast interferon (Hu IFN-beta) in the treatment of malignant tumors of the skin].
    Ishihara K
    Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):41-53. PubMed ID: 6345697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effect and histopathologic observation of malignant melanoma by intratumoral administration of HuIFN- beta].
    Ishihara K; Hayasaka K; Yamamoto A
    Gan No Rinsho; 1983 May; 29(6):603-7. PubMed ID: 6876428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trials of interferon-beta (MR-21) in the treatment of malignant tumors of the skin].
    Kukita A
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):977-86. PubMed ID: 3320228
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
    Stadler R; Bratzke B; Orfanos CE
    Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present status of cancer therapy in the field of dermatology].
    Ikeda S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):978-86. PubMed ID: 2730038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous malignant melanoma in association with mycosis fungoides.
    Evans AV; Scarisbrick JJ; Child FJ; Acland KM; Whittaker SJ; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):701-5. PubMed ID: 15097953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha 2 -interferon therapy in metastasizing malignant melanoma].
    Landthaler M; Geyer C; Papendick U; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Jun; 112(23):919-21. PubMed ID: 3582200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical stages of cutaneous malignant melanoma in Bulgaria.
    Troyanova P; Valerianova Z; Danon S
    Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
    Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
    Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The latest diagnostical methods and therapy in melanoma].
    Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
    Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal malignant melanoma associated with a completely regressed primary melanoma in a patient with cutaneous T-cell lymphoma.
    Soong V; Lee PC; Kissel RB; Sams WM; Tyring SK
    Arch Dermatol; 1987 Oct; 123(10):1270-2. PubMed ID: 3662554
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic study on interferon-beta: Part IV. Antitumor effect on nude mouse-transplanted human tumors].
    Nobuhara M; Kanamori T; Ashida Y; Horisawa Y; Harada Y; Asami T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2117-22. PubMed ID: 3717959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of malignant melanoma with beta-interferons].
    Faulhaber G; Lechner W; Röckl H
    Z Hautkr; 1988 Oct; 63(10):811-5. PubMed ID: 3239130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 203.